Scott Levick, associate professor in the West Virginia University School of Medicine Department of Physiology, Pharmacology and Toxicology, has received notification of continued funding for the research project “Substance P Metabolites and Receptors in the Pathogenesis of Cardiac Disease in Type 1 Diabetes.”
The National Institute of Diabetes and Digestive and Kidney Diseases, a part of the National Institutes of Health, awarded $714,948 for the 2026 fiscal year, which represents year three of the three-year grant totaling $2,153,284.
The project focuses on investigating the mechanisms that lead to fibrosis and vascular damage in type 1 diabetes patients and contribute to heart failure. Researchers are exploring how to activate the neurokinin 1 receptor, which regulates various heart functions, as a therapy for adverse changes in the type 1 diabetic heart.
